Interesting ImagesThe Complementary Role of 68Ga-DOTATATE PET/CT in NeuroblastomaTelli, Tuğçe MD; Lay Ergün, Eser MD; Volkan Salanci, Bilge MD; Özgen Kiratli, Pinar MDAuthor Information From the Department of Nuclear Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey. Received for publication October 31, 2019; revision accepted December 7, 2019. Conflicts of interest and sources of funding: none declared. Correspondence to: Tuğçe Telli, MD, Department of Nuclear Medicine, Faculty of Medicine, Hacettepe University, 06100 Sihhiye, Ankara, Turkey. E-mail: email@example.com, firstname.lastname@example.org. Online date: February 3, 2020 Clinical Nuclear Medicine: April 2020 - Volume 45 - Issue 4 - p 326-329 doi: 10.1097/RLU.0000000000002961 Buy Metrics Abstract A girl diagnosed with neuroblastoma at 33 months underwent 123I-MIBG scan after surgery and chemoradiotherapy. Although MIBG scan showed complete response, the bone marrow biopsy showed refractory disease. Therefore, she underwent 68Ga-DOTATATE PET/CT, which revealed bone marrow involvement and 68Ga-DOTATATE–avid brain metastasis. Rare physiological pineal gland uptake was also depicted. 68Ga-DOTATATE PET/CT showed active progressive disease earlier, before it was detectable with MIBG scan. For patients with MIBG-negative relapsed/refractory disease, 68Ga-DOTATATE may have an important role in restaging, detecting unsuspected metastasis, therapy planning. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.